Return On Assets of RELMADA THERAPEUTICS, INC. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
RELMADA THERAPEUTICS, INC. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • RELMADA THERAPEUTICS, INC. Return On Assets for the quarter ending 30 Sep 2025 was -205%, a 83% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. annual Return On Assets for 2024 was -124%, a 46% decline from 2023.
  • RELMADA THERAPEUTICS, INC. annual Return On Assets for 2023 was -85%, a 5.9% decline from 2022.
  • RELMADA THERAPEUTICS, INC. annual Return On Assets for 2022 was -80%, a 15% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

RELMADA THERAPEUTICS, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -205% -93% -83% 01 Jul 2025 30 Sep 2025
Q2 2025 -180% -85% -88% 01 Apr 2025 30 Jun 2025
Q1 2025 -151% -60% -66% 01 Jan 2025 31 Mar 2025
Q4 2024 -124% -39% -46% 01 Oct 2024 31 Dec 2024
Q3 2024 -112% -26% -30% 01 Jul 2024 30 Sep 2024
Q2 2024 -96% -9.5% -11% 01 Apr 2024 30 Jun 2024
Q1 2024 -91% -8.2% -9.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -85% -4.7% -5.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -86% -14% -19% 01 Jul 2023 30 Sep 2023
Q2 2023 -86% -3.4% -4.1% 01 Apr 2023 30 Jun 2023
Q1 2023 -83% +5% +5.6% 01 Jan 2023 31 Mar 2023
Q4 2022 -80% +15% +15% 01 Oct 2022 31 Dec 2022
Q3 2022 -72% +34% +32% 01 Jul 2022 30 Sep 2022
Q2 2022 -83% -7.5% -9.9% 01 Apr 2022 30 Jun 2022
Q1 2022 -88% -29% -50% 01 Jan 2022 31 Mar 2022
Q4 2021 -95% -47% -97% 01 Oct 2021 31 Dec 2021
Q3 2021 -106% -71% -202% 01 Jul 2021 30 Sep 2021
Q2 2021 -75% -43% -136% 01 Apr 2021 30 Jun 2021
Q1 2021 -59% -22% -61% 01 Jan 2021 31 Mar 2021
Q4 2020 -48% -4.8% -11% 01 Oct 2020 31 Dec 2020
Q3 2020 -35% +251% +88% 01 Jul 2020 30 Sep 2020
Q2 2020 -32% +360% +92% 01 Apr 2020 30 Jun 2020
Q1 2020 -37% +593% +94% 01 Jan 2020 31 Mar 2020
Q4 2019 -43% +494% +92% 01 Oct 2019 31 Dec 2019
Q3 2019 -286% -1.4% -0.5% 01 Jul 2019 30 Sep 2019
Q2 2019 -392% -213% -119% 01 Apr 2019 30 Jun 2019
Q1 2019 -630% -484% -331% 01 Jan 2019 31 Mar 2019
Q4 2018 -537% -412% -328% 01 Oct 2018 31 Dec 2018
Q3 2018 -284% -165% -138% 01 Jul 2018 30 Sep 2018
Q2 2018 -179% -60% -51% 01 Apr 2018 30 Jun 2018
Q1 2018 -146% -35% -31% 01 Jan 2018 31 Mar 2018
Q4 2017 -126% -41% -48% 01 Oct 2017 31 Dec 2017
Q3 2017 -119% -41% -53% 01 Jul 2017 30 Sep 2017
Q2 2017 -119% -99% -500% 01 Apr 2017 30 Jun 2017
Q1 2017 -112% -146% -424% 01 Jan 2017 31 Mar 2017
Q4 2016 -85% -110% -427% 01 Oct 2016 31 Dec 2016
Q3 2016 -78% -130% -251% 01 Jul 2016 30 Sep 2016
Q2 2016 -20% +54% +73% 01 Apr 2016 30 Jun 2016
Q1 2016 34% 01 Jan 2016 31 Mar 2016
Q4 2015 26% 01 Oct 2015 31 Dec 2015
Q3 2015 52% 01 Jul 2015 30 Sep 2015
Q2 2015 -74% 01 Apr 2015 30 Jun 2015

RELMADA THERAPEUTICS, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -124% -39% -46% 01 Jan 2024 31 Dec 2024
2023 -85% -4.7% -5.9% 01 Jan 2023 31 Dec 2023
2022 -80% +15% +15% 01 Jan 2022 31 Dec 2022
2021 -95% -47% -97% 01 Jan 2021 31 Dec 2021
2020 -48% -4.8% -11% 01 Jan 2020 31 Dec 2020
2019 -43% +136% +76% 01 Jan 2019 31 Dec 2019
2018 -179% -60% -51% 01 Jul 2017 30 Jun 2018
2017 -119% -99% -500% 01 Jul 2016 30 Jun 2017
2016 -20% +54% +73% 01 Jul 2015 30 Jun 2016
2015 -74% 01 Jul 2014 30 Jun 2015
2013 -336% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.